Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
LLY | Eli Lilly and Company | 66.5 | ¤696,178 | US |
NOVO.B.DK | Novo Nordisk A/S Class B | 70.7 | ¤297,522 | DK |
ISRG | Intuitive Surgical, Inc. | 66.5 | ¤192,295 | US |
MRK | Merck & Co., Inc. | 72.4 | ¤190,763 | US |
BSX | Boston Scientific Corporation | 59.6 | ¤152,176 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
SRPT | Sarepta Therapeutics, Inc. | 26.7 | ¤3,565 | US |
HLUN.B.DK | H. Lundbeck A/S Class B | 61.1 | ¤4,511 | DK |
326030.KR | SK Biopharmaceuticals Co., Ltd. | 75.0 | ¤5,072 | KR |
SFZN.CH | Siegfried Holding AG | 52.7 | ¤5,291 | CH |
ALK.B.DK | ALK-abello A/S Class B | 73.8 | ¤5,471 | DK |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
NOVO.B.DK | Novo Nordisk A/S Class B | 70.7 | 36 | DK |
BIIB | Biogen Inc. | 52.4 | 30 | US |
AMGN | Amgen Inc. | 54.2 | 29 | US |
ISRG | Intuitive Surgical, Inc. | 66.5 | 25 | US |
REGN | Regeneron Pharmaceuticals, Inc. | 57.8 | 23 | US |
RMD | ResMed Inc. | 73.0 | 23 | US |
EW | Edwards Lifesciences Corporation | 53.5 | 22 | US |
LLY | Eli Lilly and Company | 66.5 | 21 | US |
4507.JP | Shionogi & Co., Ltd. | 66.1 | 20 | JP |
4519.JP | Chugai Pharmaceutical Co., Ltd. | 66.2 | 19 | JP |
Average Market Cap | ¤54,044 |
Median Market Cap | ¤13,824 |
Avg. 3 Mo. Dollar Vol. | ¤339,912,113 |
Avg. 3 Mo. Trading Vol. | 3,724,825 |
Last Rebalance Date | 03/24/2025 |
Companies Replaced | 16 |
Biggest Industry Increase | Pharmaceuticals: Major |
Biggest Industry Decrease | Medical Specialties |
Trailing P/E Ratio (12 Mo.) | 24.0 |
Forward P/E Ratio (12 Mo.) | 18.1 |
Price/Book Ratio | 4.5 |
Avg. Revenue Chg. - 3 Yr | 42.5% |
Avg. Op. Income Chg. - 3 Yr. | 38.4% |
Avg. EPS Growth - 3 Yr. | 15.3% |
Avg. EPS Growth - 1 Yr. | 12.0% |
Avg. Operating Margin | 21.8% |
Avg. LT Debt to Total Capital | 33.3% |
Avg. Return on Equity | 20.6% |
Dividend Yield | 0% |
Developed Markets (ex-Australia) Health Care Index | 60.81 |
United States Of America | 68.0% |
Japan | 12.0% |
Denmark | 8.0% |
Korea, Republic Of | 4.0% |
Sweden | 2.0% |
Finland | 2.0% |
Ireland | 2.0% |
Switzerland | 2.0% |